Utility of serum thymus and activation-regulated chemokine as a biomarker for monitoring of atopic dermatitis severity  

Oleh:

Landheer, Janneke ; Bruin-Weller, Marjolein de ; Boonacker, Chantal ; Hijnen, DirkJan ; Bruijnzeel-Koomen, Carla ; Rockmann, Heike

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: JAAD: Journal of the American Academy of Dermatology (keterangan: ada di ClinicalKey) vol. 71 no. 06 (Dec. 2014), page 1160–1166 .
Topik: atopic dermatitis; body surface area; disease severity; follow-up; serum thymus and activation-regulated chemokine; Six Area; Six Sign Atopic Dermatitis

Ketersediaan

Perpustakaan FK Nomor Panggil: J15.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Background Serum thymus and activation-regulated chemokine (sTARC) levels reflect disease severity of atopic dermatitis (AD) in small study populations. It remains unclear whether sTARC is a reliable outcome measurement for AD severity in heterogeneous AD populations in daily practice. Objective We sought to assess the utility of sTARC as a biomarker for monitoring AD severity in adults in daily practice. Methods sTARC, clinical skin score (Six Area, Six Sign AD [SASSAD]), and body surface area measurements were collected from all adult patients with AD visiting our clinic between March 2009 and March 2012, at first visit or exacerbation (baseline). In addition, data from short-term and long-term follow-up visits were collected. Results At baseline sTARC levels ranged widely (n = 320; minimum-maximum: 3-50,400 pg/mL) and sTARC and SASSAD or body surface area correlated moderately. In the majority of patients, sTARC and SASSAD or body surface area changed congruently during follow-up. Limitations Data were collected retrospectively. Conclusion sTARC may represent a suitable biomarker for monitoring of AD severity in daily practice.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali